Military drug sales amp up with rise in new veterans, retirees

With the growing ranks of aging veterans--and growing use of chronic meds by younger veterans--the Pentagon's spending on drugs has skyrocketed, with $2.7 billion in spending on antidepressants alone. An Austin American-Statesman analysis also pinpointed $1.6 billion spent on opioid painkillers, plus $5 billion on blockbusters now off patent, or soon to be. Report

Suggested Articles

Johnson & Johnson faces a litany of problems, but executives are clearly not concerned—at least not about the company's short-term fortunes.

This week, Goldman Sachs resurrected a burning question: How can pharma companies profit from curing patients with one-time gene and cell therapies?

CMS has determined how it'll pay for Gilead's CAR-T cancer therapy, Yescarta, for outpatient use, but hasn't yet decided on Gilead's…